EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease

Robert S Rosenson, Ashley M Tate, Olga G Grushko, Dilna Damodaran, Qinzhong Chen, Michael Boffa, Marlys Koschinsky, Jagat Narula, Sascha N Goonewardena

Journal of Lipid Research · 2025-06 · 66 (6) · 100820

DOI: 10.1016/j.jlr.2025.100820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025-06. Verfasst von Robert S Rosenson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: robert.…. Hauptthemen laut MEDLINE: Lipoprotein(a), Monocytes, Inflammation, Atherosclerosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, National Heart, Lung, and Blood Institute, A. Alfred Taubman Medical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated levels of lipoprotein (a) [Lp(a)], an apolipoprotein B particle, are causally linked to atherosclerotic cardiovascular disease (ASCVD). Lp(a) is thought to promote ASCVD through multiple mechanisms, including its effects on cholesterol transport, inflammation, and thrombosis. This study defines the mechanisms that integrate Lp(a)-mediated cholesterol accumulation, inflammation, and thrombosis. In this study, we employed systems biology approaches, including proteomics, transcriptomics, and mass cytometry, to define the immune cellular and molecular phenotypes in patients with ASCVD having high and low Lp(a) levels and the molecular mechanisms through which Lp(a) mediates monocyte-driven inflammation and thrombosis. In 64 stable patients with ASCVD (41 with high Lp(a) [median Lp(a) 228.7 nmol/L] and 23 with low Lp(a) [median Lp(a) 17.8 nmol/L]), we found that circulating markers of inflammation (CCL28, IL-17D) and vascular dysfunction (tissue factor [TF]; 6.4 vs. 5.7 normalized protein expression (NPX); P = 0.01) were elevated in patients with high Lp(a) levels compared with those with low Lp(a) levels. Although total monocyte and hsCRP levels were similar between the groups, CD14+ monocytes from patients with ASCVD having an elevated Lp(a) were primed and expressed more TF at baseline and in response to stress. Mechanistically, we found that Lp(a) itself can activate monocytes through Toll-like receptor 2 (TLR2) and nuclear factor kappa B (NFκB) signaling, driving both the induction of TF and TF activity. Overall, these studies are the first to link Lp(a) to monocyte-mediated inflammation and thrombosis. This study demonstrates a novel mechanism through TLR2, NFκB, and monocyte TF by which Lp(a) amplifies immunothrombotic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)MonocytesInflammationAtherosclerosisThrombosisHumansMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

Inflammationlipoprotein(a)lipoproteinsmonocytesthrombosistissue factor

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: robert.rosenson@mssm.edu.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Ann Arbor, MI, USA.
  • Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada.
  • McGovern Medical School, University of Texas Health Sciences Center, Houston, TX, USA.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Ann Arbor, MI, USA. Electronic address: sngoonew@med.umich.edu.

Förderung

  • CSRD VA
  • National Heart, Lung, and Blood Institute
  • A. Alfred Taubman Medical Research Institute
  • National Institutes of Health

Zitieren

APA

Rosenson, R. S., Tate, A. M., Grushko, O. G., Damodaran, D., Chen, Q., Boffa, M., Koschinsky, M., Narula, J., & Goonewardena, S. N. (2025). Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease. Journal of Lipid Research, 66(6), 100820. https://doi.org/10.1016/j.jlr.2025.100820

Vancouver

Rosenson RS, Tate AM, Grushko OG, Damodaran D, Chen Q, Boffa M, et al. Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease. Journal of Lipid Research. 2025;66(6):100820. doi:10.1016/j.jlr.2025.100820

BibTeX
@article{Rosenson2025,
  author = {Rosenson, Robert S and Tate, Ashley M and Grushko, Olga G and Damodaran, Dilna and Chen, Qinzhong and Boffa, Michael and Koschinsky, Marlys and Narula, Jagat and Goonewardena, Sascha N},
  title = {Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease},
  journal = {Journal of Lipid Research},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {100820},
  doi = {10.1016/j.jlr.2025.100820}
}
Kostenlos starten →